These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 2198204

  • 1. [Detection of coagulation factor XIII in the vitreous body and periretinal membranes in proliferative retinal diseases].
    Bresgen M, Weller M, Heimann K, Wiedemann P.
    Fortschr Ophthalmol; 1990; 87(3):279-82. PubMed ID: 2198204
    [Abstract] [Full Text] [Related]

  • 2. [Thrombospondin and its importance in proliferative retinal diseases].
    Esser P, Weller M, Heimann K, Wiedemann P.
    Fortschr Ophthalmol; 1991; 88(4):337-40. PubMed ID: 1786916
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases.
    Robbins SG, Mixon RN, Wilson DJ, Hart CE, Robertson JE, Westra I, Planck SR, Rosenbaum JT.
    Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3649-63. PubMed ID: 8088954
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI, Tari SR, Lee SE, Ma W, Tseng JJ, Sosunov AA, Cataldergirmen G, Scarmeas N, Caspersen C, Chang S, Schiff WM, Schmidt AM, Barile GR.
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [Abstract] [Full Text] [Related]

  • 7. [Immunohistology of proliferative vitreoretinopathy following giant tear detachment].
    Weller M, Bresgen M, Heimann K, Wiedemann P.
    Klin Monbl Augenheilkd; 1989 Nov; 195(5):323-5. PubMed ID: 2689766
    [Abstract] [Full Text] [Related]

  • 8. Immunolocalization of integrins in proliferative retinal membranes.
    Robbins SG, Brem RB, Wilson DJ, O'Rourke LM, Robertson JE, Westra I, Planck SR, Rosenbaum JT.
    Invest Ophthalmol Vis Sci; 1994 Aug; 35(9):3475-85. PubMed ID: 8056523
    [Abstract] [Full Text] [Related]

  • 9. [Comparative immunohistochemical studies of epiretinal membranes in proliferative vitreoretinal diseases].
    Heidenkummer HP, Kampik A.
    Fortschr Ophthalmol; 1991 Aug; 88(3):219-24. PubMed ID: 1889766
    [Abstract] [Full Text] [Related]

  • 10. [Immunohistochemical findings in proliferative retinal diseases--on the significance of fibronectin, macrophages and transferrin].
    Weller M, Heimann K, Wiedemann P.
    Fortschr Ophthalmol; 1989 Aug; 86(2):121-3. PubMed ID: 2661370
    [Abstract] [Full Text] [Related]

  • 11. [Quantitative determination of 5 vitreal proteins in the normal vitreous body and proliferative retinal diseases].
    Clausen R, Weller M, Hilgers RD, Heimann K, Wiedemann P.
    Fortschr Ophthalmol; 1990 Aug; 87(3):283-6. PubMed ID: 2376377
    [Abstract] [Full Text] [Related]

  • 12. [Analysis of the protein pattern in physiologic and pathologic vitreous bodies by electrophoresis and immunologic identification].
    Bresgen M, Martiny B, Weller M, Heimann K, Wiedemann P.
    Fortschr Ophthalmol; 1991 Aug; 88(6):665-70. PubMed ID: 1794787
    [Abstract] [Full Text] [Related]

  • 13. [Contractile elements in proliferative retinal diseases].
    Molitor R, Esser P, Weller M, Wiedemann P, Heimann K.
    Ophthalmologe; 1992 Feb; 89(1):34-8. PubMed ID: 1581690
    [Abstract] [Full Text] [Related]

  • 14. [Idiopathic proliferative vitreoretinopathy. Activation of microglial cells as the deciding factor].
    Weller M, Esser P, Heimann K, Wiedemann P.
    Ophthalmologe; 1992 Oct; 89(5):387-90. PubMed ID: 1304218
    [Abstract] [Full Text] [Related]

  • 15. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Abu El-Asrar AM, Struyf S, Kangave D, Geboes K, Van Damme J.
    Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
    [Abstract] [Full Text] [Related]

  • 16. Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-beta-induced RPE cell apoptosis.
    Esser P, Heimann K, Bartz-schmidt KU, Fontana A, Schraermeyer U, Thumann G, Weller M.
    Exp Eye Res; 1997 Sep; 65(3):365-78. PubMed ID: 9299173
    [Abstract] [Full Text] [Related]

  • 17. [Immunohistochemical study on vitrectomy specimens of proliferative retinal diseases].
    Cao J, Wu L, Zhang H.
    Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):264-7. PubMed ID: 10451957
    [Abstract] [Full Text] [Related]

  • 18. Management of proliferative diabetic retinopathy.
    Gündüz K, Bakri SJ.
    Compr Ophthalmol Update; 2007 Jul; 8(5):245-56. PubMed ID: 18201511
    [Abstract] [Full Text] [Related]

  • 19. Intercellular adhesion molecule-1 levels in plasma and vitreous from patients with vitreoretinal disorders.
    Esser P, Bresgen M, Fischbach R, Heimann K, Wiedemann P.
    Ger J Ophthalmol; 1995 Sep; 4(5):269-74. PubMed ID: 7496336
    [Abstract] [Full Text] [Related]

  • 20. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
    Rollin R, Mediero A, Martínez-Montero JC, Roldán-Pallarés M, Suárez-Leoz M, Vidal-Fernández P, Cortés-Valdés C, Fernández-Cruz A, Fernández-Durango R.
    Mol Vis; 2004 Jul 15; 10():450-7. PubMed ID: 15273657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.